Background: In the U.S., Puerto Ricans and Mexicans have the highest and lowest
Introduction (word count = 451)
Studies of racial/ethnic health disparities often define populations based on U.S. census definitions, which categorize Latinos as a single ethnic group. Latinos are the largest minority population in the U.S., and Latino children represent the largest demographic group of all U.S. children. 1 Although, the terms "Hispanic" or "Latino" American describe a common language and cultural heritage, these terms do not refer to race, uniform ethnicity or a common genetic background. The two largest Latino ethnic groups in the U.S., Mexicans (63%) and Puerto Ricans (11%), 1 are genetically complex and comprised of various proportions of Native American, African and European genetic origins. 2 The relative proportions of these ancestral populations to the contemporary Latino gene pool make each Latino ethnic group genetically unique. 2 According to U.S. vital statistics, asthma prevalence, morbidity and mortality are the highest among Puerto Ricans and the lowest among Mexicans for a total of four-fold difference in asthma burden between these two ethnic groups. 3, 4 Although there are many potential explanations for this observation, including environmental and socioeconomic factors, one potential explanation is that the genetic predisposition to asthma or to greater asthma severity differs among subgroups within the Latino population. These subgroups may have genetic variants, which may explain the variation in asthma severity and response to drug therapy between Latino ethnic groups.
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Albuterol, a short-acting beta 2 adrenergic receptor (β 2 AR) agonist, is the most commonly prescribed treatment for asthma worldwide. 5 β 2 AR mediates physiologic responses including bronchial smooth muscle relaxation (bronchodilation), vasodilatation and lipolysis. 6 Genetic variations at the β 2 AR gene may play a role in the observed ethnicspecific differences in asthma severity and bronchodilator drug responsiveness.
Polymorphisms in the β 2 AR gene have been inconsistently associated with varying degrees of bronchodilatory response to β-agonists [7] [8] [9] [10] [11] [12] and with tachyphylaxis. 13, 14 In one study, specific haplotypes, as opposed to individual single nucleotide polymorphisms (SNPs), were significantly associated with drug responsiveness. 12 Consequently, there is no clear consensus regarding the extent to which genetic variants in the β 2 AR gene may influence asthma severity or bronchodilator drug responsiveness.
We used a family-based genetic association study to determine whether polymorphisms (SNPs and haplotypes) in the β 2 AR gene are associated with ethnic-specific differences in asthma severity and bronchodilator response in Puerto Rican and Mexican subjects with asthma participating in the Genetics of Asthma in Latino Americans (GALA) Study.
We selected a family-based approach because it removes the effect of population stratification, a potentially important source of confounding. 15 Spurious associations between genetic variants and phenotypes may arise as a result of population stratification when non-family based approaches are used. 16 Moreover, racial and ethnic background can influence genetic variation and genotypic relative risk. 17 Some of the results of this study have been previously reported in the form of an abstract. 18 
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Subjects and Methods (word count = 545
Study Participants
Recruitment and pulmonary function testing are described elsewhere and in detail in the online supplement. 19 Briefly, 684 asthmatic subjects (probands) and their biological parents were enrolled in the San Francisco Bay Area (SF), New York City (NY), Puerto
Rico (PR), and Mexico City (MX). Clinical characteristics of all probands are shown in Table 1 . Ethnicity was self-reported. Probands were enrolled only if both biological parents and all four biological grandparents were of Puerto Rican (for the NY and PR sites) or Mexican ethnicity (for the SF and MX sites).
Pulmonary Function Tests and IgE measurements
Spirometry was performed according to ATS standards. 20 Pulmonary function test results are shown in Table 1 and are expressed as a percentage of the predicted normal value using age-adjusted prediction equations from Hankinson.
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Asthmatic probands were classified as having "mild" or "moderate-severe" asthma based on their baseline Forced Expiratory Volume in one second (FEV 1 ) expressed as percent of predicted or Pre-FEV 1 levels. Patients with Pre-FEV 1 greater or less than 80% of predicted were categorized as having "mild" and "moderate-severe" asthma, respectively.
A quantitative measure of bronchodilator responsiveness was calculated as Delta FEV 1 , which is relative percent change in Pre-FEV 1 after albuterol administration. Total plasma IgE was measured in duplicate using Uni-Cap technology (Pharmacia, Kalamazoo, MI).
Genotyping
Genotyping details are described further in the online supplement. Eight β 2 AR SNPs (-709, -654, -47, +46, +79, +252, +491 , and +523) were genotyped and used to assign haplotypes.
Statistical Analysis
Statistical analyses are further described in the online supplement. Mendelian inconsistencies were identified using PEDCHECK. 22 
Results

Allele Frequencies, Hardy-Weinberg Equilibrium and Linkage Disequilibrium
Of the 684 GALA trios, we obtained genotyping information for 667 trios, which were used for these analyses. The allele frequencies of 8 β 2 AR SNPs in the combined (Puerto Rican and Mexican together), Puerto Rican and Mexican probands are listed in Table 2 .
All SNPs were found to be in conformance with Hardy-Weinberg equilibrium with the (Table 4) . Therefore, all subsequent analyses were performed in each ethnic group separately. Family-based analyses were used to test for associations between individual SNPs and Pre-FEV 1 , Delta FEV 1 and log IgE. Among
Puerto Ricans, significant associations (p = 0.04-0.002) were found for SNPs -654, -47, +46 and +79 and Pre-FEV 1 and Delta FEV 1 (Table 4) . Among Mexicans, Gln27 was modestly associated (p = 0.04) with Delta FEV 1 ( Table 4 ). There were no significant associations between individual SNPs and IgE levels in either Puerto Ricans or
Mexicans.
Since family-based analyses suggested an association between SNPs and bronchodilator response, we tested the clinical magnitude of the effect of the Arg16Gly polymorphism on bronchodilator response by cross-sectional analysis in Puerto Ricans and Mexicans separately. Regression analysis showed a highly significant association between number of Arg16 alleles and bronchodilator response in all Puerto Rican asthmatics (p = 0.002) and in those with Pre-FEV 1 less than 80% of predicted (p = 0.0001), Figure 2 . This association was independent of age and albuterol dosage used for performing spirometry.
Among all Puerto Rican subjects, the mean values of Delta FEV 1 stratified by codon 16
were as follows: individuals with Arg16/Arg16 (10.46% ± 2.44%), Arg16/Gly16 (6.13% ± 0.74%); and with Gly16/Gly16 (3.85% ± 0.99%). When the Puerto Rican probands were stratified based on Pre-FEV 1 less than or greater than 80%, Arg16 was significantly associated with higher levels of bronchodilator response among Puerto Rican asthmatics with Pre-FEV 1 less than 80%; Arg16/Arg16 (24.9% ± 6.86%) (n = 23), Arg16/Gly16 (8.8% ± 1.2%) (n = 70); and with Gly16/Gly16 (4.3% ± 2.2%) (n = 39). The 95%
confidence interval for the difference of 20.6% ± 4.5% that we observed in bronchodilator drug responsiveness between Arg16/Arg16 and Gly16/Gly16 genotypes was 11.7% -29.5%. Using an additive model, we found a mean increase of ~ 3% Figure 2 ) and Mexican asthmatics with Pre-FEV 1 less than 80% (p = 0.72) or greater than 80% (p = 0.16). The results of these cross sectional analysis did not change when corrected for population stratification (see on line supplement for further details).
Haplotype-based Association Analysis
A total of seven, five and six different haplotypes (frequency of > 1%) were observed in the Puerto Rican, Mexican and both populations combined, respectively ( Table 2) .
Haplotype associations differed between Puerto Ricans and Mexicans. However, haplotype results were consistent with single SNP results for Puerto Ricans and Mexicans, respectively, and analyses of the three most common haplotypes are presented in Table 5 . Haplotype 1 (which carried the Arg16 allele) and haplotype 2 (which carried the Gly 16 allele) were over-transmitted in Puerto Rican patients with Delta FEV 1 > 12%
and Delta FEV 1 < 12%, respectively. We did not find any association between the haplotypes and Delta FEV 1 among Mexicans (Table 5 ).
The three most common eight SNP haplotypes identified in the Puerto Rican and Mexican populations could be distinguished from each other using only 2 SNPs, (+46 and +79), which code for codon 16 and codon 27, respectively. Phase for the 2 SNP haplotypes were imputed for both Puerto Rican and Mexican probands using the Phamily Phase program. 26 The 2 SNP haplotypes were assembled as pairs and 6 common haplotype pairs with greater than 1% frequency were observed in Puerto Rican and We have previously demonstrated that asthmatic Puerto Ricans have significantly more airway obstruction, more health care utilization and lower bronchodilator response to albuterol than asthmatic Mexicans. 19 Although our results do not entirely explain the significant disparities in asthma prevalence, morbidity and mortality among Latino ethnic groups, our study raises several provocative issues regarding ethnic-specific pharmacogenetic differences between these two populations. This large family-based study consists of two well-characterized, ethnically diverse populations of Puerto Rican and Mexican asthmatics from four geographically diverse locations. Studies performed in these populations may have important public health implications since Latino children represent the largest demographic group of all U.S. children 1 and since asthma morbidity and mortality are highest amongst Puerto Ricans and the lowest amongst Mexicans for a four-fold difference in asthma burden between these two ethnic groups. 3, 4 The fact that Puerto Ricans and Mexicans have the highest and lowest asthma prevalence, morbidity and mortality, respectively, underscores the clinical significance and public health implications of these findings.
Our study demonstrates that the two largest Latino ethnic groups in the U.S. have different patterns of linkage disequilibrium, haplotypes and pharmacogenetic associations, and therefore should be considered as separate groups in future drug trials and pharmacogenetic studies of asthma. Ethnic-specific pharmacogenetic differences among asthmatics have not been previously reported and thus merit further investigation. For quantitative traits, the allele in the parenthesis was associated with higher value of the trait. For qualitative traits, the allele in the parenthesis was over-transmitted to asthmatic probands. All other p-values are not shown because they were not significant. For quantitative traits, the allele in the parenthesis was associated with higher value of the trait. For qualitative traits, the allele in the parenthesis was over-transmitted to asthmatic probands. All other p-values for both ethnic groups are not shown because they were not significant. For quantitative traits, the p-values in bold represent haplotypes over-transmitted to asthmatic probands. All other p-values are not shown because they were not significant. Delta FEV 1 (relative % pred)
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